One year safety and immunogenicity of AZD1222 (ChAdOx1 nCoV-19): Final analysis of a randomized, placebo-controlled phase 1/2 trial in Japan
- Resource Type
- Short Communication
- Source
- In
Vaccine 29 June 2023 41(29):4199-4205 - Subject
- Language
- ISSN
- 0264-410X